genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
One COVID-19 Shot, Two Approaches
Bioprocessing
Waters Opens Cambridge, MA, Collaboration Lab
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
News
Coronavirus
FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
Coronavirus
BARDA Balks at “Warp Speed” Funding for Oragenics COVID-19 Vaccine
Cancer
Researchers Keep Cancer Cells Out by Blocking the Gate to the…
Alzheimers
Alzheimer’s Epigenetic Drivers Identified
Coronavirus
Specific T Cells Activated in Severe COVID-19 Cases
Insights
All
Trends for 2020
Bioprocessing
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Bioprocessing
Cytiva Tests Filtration for Lentivirus Production
Bioprocessing
Observing the Performance of Planova Filters
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
eBooks
The Future of Drug Discovery
Bioprocessing
Continuous Bioprocessing and 4.0 Tech Key to Bypassing Bottlenecks
Bioprocessing
Cytiva Tests Filtration for Lentivirus Production
Coronavirus
FDA Places Partial Clinical Hold on INOVIO Trial of COVID-19 Vaccine
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Head and Neck Cancer
Head and Neck Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Head and Neck Cancer
Critical Recurring Mutation Identified in Head and Neck Cancers
Head and Neck Cancer
BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B Financing
Head and Neck Cancer
After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca Combination
Head and Neck Cancer
Biofilms in Tonsil Crypts May Explain HPV-Related Head and Neck Cancers
Head and Neck Cancer
PDS, Merck Agree to Phase II Combo Study with Keytruda and Versamune Immunotherapy
Head and Neck Cancer
PD-L2 Helps Predict Immunotherapy Responsiveness for Head and Neck Cancer
Head and Neck Cancer
XOMA Licenses TGFb Immuno-Oncology Program to Novartis for Up to $517M+
Head and Neck Cancer
MedImmune, 3M Partner to Develop TLR Agonist Cancer Treatments
Head and Neck Cancer
Neuroblastoma Deploys Energy-Draining Weapon against Immune System
Head and Neck Cancer
Spit and Blood Tests Successfully Detect Tumor DNA from Head and...
Head and Neck Cancer
Drug-Resistant Neuroblastoma Aided by miRNA in Tumor Microenviroment
Head and Neck Cancer
Tampering with Superenhancer Mechanism Stalls Oncoprotein’s Vicious Cycle
Head and Neck Cancer
Kadmon and NIH Agree to Evaluate Gene Therapy Approach
Head and Neck Cancer
$2.437M Grant to Fund NY Genome Center Pediatric Cancer Research Effort
Head and Neck Cancer
Memorial Sloan-Kettering to Use Sutro Technology for Neuroblastoma Research
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Human papilloma virus (HPV) encased in biofilms inside tonsil crypts (pictured) may explain why the roughly 5% of HPV-infected people who develop cancer of the mouth or throat are not protected by their immune systems. Tonsil crypts with HPV are shown in green; epithelial and biofilm layers are shown in red. [Katherine Rieth. M.D.]](https://www.genengnews.com/wp-content/uploads/2018/08/161800_web6814447402-265x198.jpg "Biofilms in Tonsil Crypts May Explain HPV-Related Head and Neck Cancers")